TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 144.45M | 151.70M | 171.92M | 190.29M | 91.77M |
| Total Depreciation and Amortization | 37.41M | 34.02M | 30.91M | 25.89M | 24.60M |
| Total Amortization of Deferred Charges | 3.00M | 2.40M | 2.00M | 1.30M | 800.00K |
| Total Other Non-Cash Items | -14.32M | -27.99M | -36.03M | -43.01M | 42.94M |
| Change in Net Operating Assets | -58.19M | -14.21M | 51.42M | 18.38M | 17.88M |
| Cash from Operations | 112.36M | 145.93M | 220.23M | 192.84M | 177.99M |
| Capital Expenditure | -67.66M | -66.89M | -68.87M | -59.25M | -57.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.31M | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -72.97M | -66.89M | -68.87M | -59.25M | -57.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 11.23M | 11.79M | 17.87M | 17.00M | 15.08M |
| Repurchase of Common Stock | -317.00K | -315.00K | -276.00K | -138.00K | -138.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.92M | 11.47M | 17.59M | 16.86M | 14.94M |
| Foreign Exchange rate Adjustments | -576.00K | -475.00K | 585.00K | 1.27M | 489.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.73M | 90.04M | 169.53M | 151.72M | 136.08M |